Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives

IF 3.3 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Chemical Biology & Drug Design Pub Date : 2025-03-06 DOI:10.1111/cbdd.70079
Bing He, Hong-zhou Tan, Cheng-bo Liu, Hong Wu, Li-qin He
{"title":"Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives","authors":"Bing He,&nbsp;Hong-zhou Tan,&nbsp;Cheng-bo Liu,&nbsp;Hong Wu,&nbsp;Li-qin He","doi":"10.1111/cbdd.70079","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>A novel class of chalcone Mannich base derivatives <b>I</b><sub><b>1-9</b></sub> and <b>II</b><sub><b>1-11</b></sub> was synthesized, which exhibited significant antiproliferation activities in five different cancer cells. The activities of most compounds were superior to those of the positive control drug 5-FU. Moreover, compared with the intermediate chalcone, their water solubility was also significantly enhanced. Among them, the most prospective compound <b>I</b><sub><b>4</b></sub> (IC<sub>50</sub> = 3.09–5.08 μM for the tested cancer cells) can effectively inhibit the proliferation of A549/DDP cells (IC<sub>50</sub> = 4.69 μM). Further mechanistic studies revealed that it can induce apoptosis of A549 and A549/DDP cells by arresting the G2/M phase of the cell cycle. Although the selectivity of compound <b>I</b><sub><b>4</b></sub> between tumor cells and normal cells was not obvious, it might be a promising lead compound for lung cancer and is worthy of further investigation.</p>\n </div>","PeriodicalId":143,"journal":{"name":"Chemical Biology & Drug Design","volume":"105 3","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Biology & Drug Design","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cbdd.70079","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

A novel class of chalcone Mannich base derivatives I1-9 and II1-11 was synthesized, which exhibited significant antiproliferation activities in five different cancer cells. The activities of most compounds were superior to those of the positive control drug 5-FU. Moreover, compared with the intermediate chalcone, their water solubility was also significantly enhanced. Among them, the most prospective compound I4 (IC50 = 3.09–5.08 μM for the tested cancer cells) can effectively inhibit the proliferation of A549/DDP cells (IC50 = 4.69 μM). Further mechanistic studies revealed that it can induce apoptosis of A549 and A549/DDP cells by arresting the G2/M phase of the cell cycle. Although the selectivity of compound I4 between tumor cells and normal cells was not obvious, it might be a promising lead compound for lung cancer and is worthy of further investigation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一类新型查尔酮曼尼希碱衍生物的合成及抗肿瘤评价
合成了一类新的查尔酮曼尼希碱衍生物I1-9和i1 -11,它们在5种不同的肿瘤细胞中表现出明显的抗增殖活性。大部分化合物的活性优于阳性对照药物5-FU。此外,与中间体查尔酮相比,它们的水溶性也显著提高。其中,最有前景的化合物I4 (IC50 = 3.09-5.08 μM)能有效抑制A549/DDP细胞(IC50 = 4.69 μM)的增殖。进一步的机制研究表明,它可以通过阻滞细胞周期的G2/M期诱导A549和A549/DDP细胞凋亡。虽然化合物I4在肿瘤细胞和正常细胞之间的选择性不明显,但它可能是一种有前景的治疗肺癌的先导化合物,值得进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Chemical Biology & Drug Design
Chemical Biology & Drug Design 医学-生化与分子生物学
CiteScore
5.10
自引率
3.30%
发文量
164
审稿时长
4.4 months
期刊介绍: Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.
期刊最新文献
Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases Epigallocatechin Gallate, Resveratrol, and Triptolide Are Candidate Natural Drugs Which Target Huh Proteins in Atherosclerosis Pathogenesis Anti-Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells Quercetin Suppresses Inflammation and Extracellular Matrix Degradation in Knee Osteoarthritis by Inhibiting E2F2 to Modulate SFRP5/Wnt5a Signaling Correction to “Targeting the Autophagy–Apoptosis Axis in Osteosarcoma: Therapeutic Potential of Biocompounds: A Review”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1